Suppr超能文献

隐藏成本:资源有限环境下卫生干预措施成本效益分析的伦理问题。

Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.

机构信息

a Department of Health Policy and Management , University of North Carolina-Chapel Hill , Chapel Hill , NC , USA.

b Division of Infectious Diseases , University of North Carolina-Chapel Hill , Chapel Hill , NC , USA.

出版信息

Glob Public Health. 2017 Oct;12(10):1269-1281. doi: 10.1080/17441692.2016.1178319. Epub 2016 May 4.

Abstract

Cost-effectiveness analysis (CEA) is an increasingly appealing tool for evaluating and comparing health-related interventions in resource-limited settings. The goal is to inform decision-makers regarding the health benefits and associated costs of alternative interventions, helping guide allocation of limited resources by prioritising interventions that offer the most health for the least money. Although only one component of a more complex decision-making process, CEAs influence the distribution of health-care resources, directly influencing morbidity and mortality for the world's most vulnerable populations. However, CEA-associated measures are frequently setting-specific valuations, and CEA outcomes may violate ethical principles of equity and distributive justice. We examine the assumptions and analytical tools used in CEAs that may conflict with societal values. We then evaluate contextual features unique to resource-limited settings, including the source of health-state utilities and disability weights, implications of CEA thresholds in light of economic uncertainty, and the role of external donors. Finally, we explore opportunities to help align interpretation of CEA outcomes with values and budgetary constraints in resource-limited settings. The ethical implications of CEAs in resource-limited settings are vast. It is imperative that CEA outcome summary measures and implementation thresholds adequately reflect societal values and ethical priorities in resource-limited settings.

摘要

成本效益分析(CEA)是评估和比较资源有限环境下健康相关干预措施的一种越来越有吸引力的工具。其目标是为决策者提供替代干预措施的健康效益和相关成本信息,通过优先考虑为最少的钱提供最多健康的干预措施来帮助指导有限资源的分配。虽然 CEA 只是更复杂决策过程的一个组成部分,但它会直接影响世界上最脆弱人群的发病率和死亡率,从而影响医疗保健资源的分配。然而,CEA 相关措施通常是特定于情境的估值,并且 CEA 结果可能违反公平和分配正义的伦理原则。我们研究了可能与社会价值观相冲突的 CEA 中使用的假设和分析工具。然后,我们评估了资源有限环境中的独特情境特征,包括健康状态效用和残疾权重的来源、在经济不确定性下 CEA 阈值的影响,以及外部捐助者的作用。最后,我们探讨了帮助在资源有限环境中使 CEA 结果的解释与价值观和预算限制保持一致的机会。CEA 在资源有限环境中的伦理影响是巨大的。至关重要的是,CEA 结果总结指标和实施阈值应充分反映资源有限环境中的社会价值观和伦理优先事项。

相似文献

1
Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.
Glob Public Health. 2017 Oct;12(10):1269-1281. doi: 10.1080/17441692.2016.1178319. Epub 2016 May 4.
2
Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Health Policy. 2005 Oct;74(2):146-56. doi: 10.1016/j.healthpol.2004.12.015. Epub 2005 Jan 26.
3
Health care input constraints and cost effectiveness analysis decision rules.
Soc Sci Med. 2018 Mar;200:59-64. doi: 10.1016/j.socscimed.2018.01.026. Epub 2018 Jan 28.
4
Quality-adjusted life-years. Ethical implications for physicians and policymakers.
JAMA. 1990 Jun 6;263(21):2917-21. doi: 10.1001/jama.263.21.2917.
7
Ethics and resource allocation: an economist's view.
Soc Sci Med. 1986;22(11):1167-74. doi: 10.1016/0277-9536(86)90183-8.
8
Generalisability in economic evaluation studies in healthcare: a review and case studies.
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490.
9
Generalizability of cost-utility analyses across countries and settings.
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):845-52. doi: 10.1016/j.bpg.2013.08.017. Epub 2013 Sep 26.
10
The role of health economics in clinical decision-making: is it ethical?
Respir Med. 1991 Sep;85 Suppl B:3-5. doi: 10.1016/s0954-6111(06)80161-7.

引用本文的文献

2
Factors influencing patients to choose one obesity treatment over another: a qualitative study.
Int J Obes (Lond). 2025 Apr 24. doi: 10.1038/s41366-025-01789-3.
3
Optimizing the Harms and Benefits of Cervical Screening in a Partially Vaccinated Population in Ontario, Canada: A Modeling Study.
Med Decis Making. 2025 Jul;45(5):545-556. doi: 10.1177/0272989X251332597. Epub 2025 Apr 22.
4
Turning back the clock: reintroducing 'SAFE' principles to spinal cord stimulation for long-term therapy preservation.
Pain Manag. 2025 Feb;15(2):55-57. doi: 10.1080/17581869.2025.2455372. Epub 2025 Jan 21.
5
Reframing Optimal Control Problems for Infectious Disease Management in Low-Income Countries.
Bull Math Biol. 2023 Mar 12;85(4):31. doi: 10.1007/s11538-023-01137-4.
6
Children First, a Debate on the Restrictions to Tackle COVID-19.
Children (Basel). 2023 Jan 25;10(2):211. doi: 10.3390/children10020211.
9
Economic value of protected areas via visitor mental health.
Nat Commun. 2019 Nov 12;10(1):5005. doi: 10.1038/s41467-019-12631-6.
10
Variation in the methodological approach to productivity cost valuation: the case of prostate cancer.
Eur J Health Econ. 2019 Dec;20(9):1399-1408. doi: 10.1007/s10198-019-01098-3. Epub 2019 Aug 23.

本文引用的文献

1
Cost-value analysis of health interventions: introduction and update on methods and preference data.
Pharmacoeconomics. 2015 Feb;33(2):89-95. doi: 10.1007/s40273-014-0212-4.
2
5
Multiple criteria decision analysis for health technology assessment.
Value Health. 2012 Dec;15(8):1172-81. doi: 10.1016/j.jval.2012.06.015. Epub 2012 Oct 6.
6
Inquiry into the relationship between equity weights and the value of the QALY.
Value Health. 2012 Dec;15(8):1119-26. doi: 10.1016/j.jval.2012.07.002. Epub 2012 Sep 25.
7
Can cost-effectiveness analysis integrate concerns for equity? Systematic review.
Int J Technol Assess Health Care. 2012 Apr;28(2):125-32. doi: 10.1017/S0266462312000050. Epub 2012 Apr 12.
8
Allocating funds for HIV/AIDS: a descriptive study of KwaDukuza, South Africa.
Health Policy Plan. 2011 Jan;26(1):33-42. doi: 10.1093/heapol/czq022. Epub 2010 Jun 15.
9
Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.
Pharmacoeconomics. 2009;27(11):903-17. doi: 10.2165/10899580-000000000-00000.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验